We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Lifecell Corp (MM) | NASDAQ:LIFC | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 51.05 | 0 | 01:00:00 |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4)
OF THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
LIFECELL CORPORATION
(Name of Subject Company)
LIFECELL CORPORATION
(Name of Person Filing Statement)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)
531927101
(CUSIP Number of Class of Securities)
Paul G. Thomas
Chairman of the Board, President and Chief Executive Officer
LifeCell Corporation
One Millennium Way
Branchburg, New Jersey 08876
(908) 947-1100
(Name, address and telephone number of person authorized to receive
notice and communications on behalf of the person filing statement)
Copies to:
Alan Wovsaniker, Esq. |
Steven M. Skolnick, Esq. |
Lowenstein Sandler PC |
65 Livingston Avenue |
Roseland, NJ 07068 |
(973) 597-2500 |
¨ | Check the box if the filing relates to preliminary communications made before the commencement date of a tender offer. |
Introduction
This Amendment No. 1 to Schedule 14D-9 amends and supplements the Solicitation/Recommendation Statement on Schedule 14D-9 (the Schedule 14D-9 ) originally filed with the U.S. Securities and Exchange Commission (the SEC ) by LifeCell Corporation, a Delaware corporation (the Company ), on April 21, 2008. Except as otherwise noted, the information set forth in the original Schedule 14D-9 remains unchanged. Capitalized terms used but not defined herein have the meaning ascribed to them in the Schedule 14D-9.
ITEM 9. EXHIBITS
Item 9 of the Schedule 14D-9 is hereby amended and supplemented by adding the following exhibit:
(a | )(5)(vi) | Joint Press Release Issued by KCI and the Company on April 21, 2008 Announcing Commencement of Tender Offer. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LIFECELL CORPORATION | ||
By: | /s/ Steven T. Sobieski | |
Steven T. Sobieski | ||
Chief Financial Officer |
Date: April 21, 2008
1 Year Lifecell Corp (MM) Chart |
1 Month Lifecell Corp (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions